Share Price and Basic Stock Data
Last Updated: December 5, 2025, 6:32 pm
| PEG Ratio | 0.94 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Krishana Phoschem Ltd operates in the fertilisers sector, a critical component of India’s agricultural backbone. The company reported a significant surge in revenues, with sales increasing from ₹323 Cr in FY 2023 to ₹1,358 Cr in FY 2025, reflecting an impressive compound annual growth rate (CAGR). This growth trajectory is particularly notable when considering quarterly sales, which surged to ₹301 Cr by September 2024, before peaking at ₹473 Cr in March 2025. Such robust revenue growth underscores strong demand for fertilisers, possibly driven by rising agricultural activity and the government’s focus on enhancing food production. The company’s revenue from operations per share stood at ₹219.68, a marked improvement from ₹149.43 in the previous year, indicating effective scaling of operations.
Profitability and Efficiency Metrics
Krishana Phoschem’s profitability metrics reveal a company that is navigating the competitive landscape effectively. The operating profit margin (OPM) hovered around 14% in FY 2025, consistent with previous years, reflecting the company’s ability to manage costs while capitalising on revenue growth. Net profit for the same period rose to ₹87 Cr, translating to an earnings per share (EPS) of ₹14.00, a substantial increase from ₹6.54 in FY 2024. However, the OPM has shown some fluctuations, dipping to 10% in FY 2024. Efficiency ratios such as return on equity (ROE) at 22.54% and return on capital employed (ROCE) at 27.68% indicate that the company is generating good returns relative to shareholder equity and capital investment, a positive sign for potential investors.
Balance Sheet Strength and Financial Ratios
A closer examination of Krishana Phoschem’s balance sheet reveals a company that is navigating its financial obligations with relative ease. As of FY 2025, total borrowings stood at ₹376 Cr, down from ₹436 Cr in FY 2024, suggesting a deliberate strategy to reduce debt levels. The interest coverage ratio (ICR) of 4.91x indicates that the company comfortably meets its interest obligations, which is a reassuring sign for stakeholders. However, the total debt to equity ratio at 0.97x suggests a relatively leveraged position, which could become a concern if market conditions shift unfavourably. The company’s reserves have also grown significantly, reaching ₹322 Cr, which enhances its financial flexibility and capacity for future investments.
Shareholding Pattern and Investor Confidence
In terms of shareholding, Krishana Phoschem presents a stable picture with promoters holding a significant 71.96% stake. This level of promoter commitment often instils confidence among investors, as it indicates alignment of interests. The public holding has seen a gradual decline, from 35.17% in December 2022 to 27.44% in September 2025, which may raise questions about liquidity and market participation. Interestingly, foreign institutional investors (FIIs) have started to show interest, albeit modestly, with their stake increasing to 0.60% by September 2025. This gradual uptick might reflect growing confidence in the company’s potential among international investors, reinforcing the notion that Krishana Phoschem is on the radar of savvy market participants.
Outlook, Risks, and Final Insight
Looking ahead, Krishana Phoschem Ltd appears well-positioned to capitalise on the growing demand for fertilisers, supported by strong revenue growth and solid profitability metrics. However, risks remain, particularly in terms of its leverage and the fluctuation in margins. The company must navigate raw material costs and regulatory challenges that could affect profitability. Additionally, while the increasing interest from FIIs is promising, the declining public shareholding could signal potential liquidity issues. Investors should consider these factors carefully, weighing the company’s growth potential against the backdrop of economic conditions and agricultural trends in India. Overall, Krishana Phoschem’s story is one of growth, but it comes with its share of complexities and challenges that warrant close monitoring.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Krishana Phoschem Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 7,138 Cr. | 179 | 231/156 | 10.7 | 313 | 2.79 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 174 Cr. | 32.9 | 85.0/30.0 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 110 Cr. | 12.1 | 20.2/11.0 | 21.8 | 20.0 | 0.41 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,240 Cr. | 295 | 395/155 | 3.59 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,697 Cr. | 83.3 | 128/66.2 | 9.13 | 63.8 | 2.40 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,671.33 Cr | 395.50 | 49.01 | 185.72 | 0.96% | 13.03% | 10.58% | 6.96 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66 | 65 | 47 | 145 | 165 | 265 | 230 | 263 | 281 | 301 | 304 | 473 | 396 |
| Expenses | 57 | 50 | 38 | 127 | 133 | 218 | 207 | 238 | 239 | 260 | 260 | 417 | 330 |
| Operating Profit | 9 | 15 | 9 | 19 | 32 | 47 | 24 | 26 | 42 | 40 | 44 | 56 | 66 |
| OPM % | 14% | 24% | 18% | 13% | 20% | 18% | 10% | 10% | 15% | 13% | 15% | 12% | 17% |
| Other Income | 1 | 0 | 1 | 1 | 1 | -1 | 0 | 1 | 1 | 2 | 2 | 6 | 3 |
| Interest | 1 | 2 | 1 | 3 | 7 | 10 | 9 | 11 | 12 | 10 | 9 | 8 | 9 |
| Depreciation | 2 | 2 | 2 | 2 | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 8 | 8 |
| Profit before tax | 7 | 12 | 6 | 14 | 18 | 28 | 6 | 7 | 23 | 25 | 29 | 47 | 51 |
| Tax % | 17% | 17% | 18% | 56% | 33% | 32% | 41% | 17% | 28% | 32% | 29% | 30% | 40% |
| Net Profit | 6 | 10 | 5 | 6 | 12 | 19 | 4 | 6 | 16 | 17 | 21 | 33 | 31 |
| EPS in Rs | 1.03 | 1.65 | 0.78 | 1.05 | 2.00 | 3.25 | 0.61 | 0.92 | 2.71 | 2.76 | 3.39 | 5.43 | 5.05 |
Last Updated: August 1, 2025, 6:10 pm
Below is a detailed analysis of the quarterly data for Krishana Phoschem Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 396.00 Cr.. The value appears to be declining and may need further review. It has decreased from 473.00 Cr. (Mar 2025) to 396.00 Cr., marking a decrease of 77.00 Cr..
- For Expenses, as of Jun 2025, the value is 330.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 417.00 Cr. (Mar 2025) to 330.00 Cr., marking a decrease of 87.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 56.00 Cr. (Mar 2025) to 66.00 Cr., marking an increase of 10.00 Cr..
- For OPM %, as of Jun 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Mar 2025) to 17.00%, marking an increase of 5.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 51.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2025) to 51.00 Cr., marking an increase of 4.00 Cr..
- For Tax %, as of Jun 2025, the value is 40.00%. The value appears to be increasing, which may not be favorable. It has increased from 30.00% (Mar 2025) to 40.00%, marking an increase of 10.00%.
- For Net Profit, as of Jun 2025, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 33.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 5.05. The value appears to be declining and may need further review. It has decreased from 5.43 (Mar 2025) to 5.05, marking a decrease of 0.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: July 22, 2025, 3:29 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 90 | 73 | 89 | 80 | 96 | 146 | 162 | 188 | 318 | 323 | 924 | 1,358 | 1,473 |
| Expenses | 75 | 63 | 77 | 64 | 77 | 112 | 127 | 149 | 263 | 271 | 795 | 1,174 | 1,267 |
| Operating Profit | 15 | 10 | 12 | 15 | 19 | 33 | 35 | 39 | 56 | 52 | 129 | 184 | 206 |
| OPM % | 17% | 13% | 13% | 19% | 20% | 23% | 22% | 21% | 17% | 16% | 14% | 14% | 14% |
| Other Income | 0 | 4 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 3 | 1 | 10 | 13 |
| Interest | 4 | 5 | 5 | 4 | 6 | 3 | 3 | 2 | 4 | 7 | 37 | 39 | 37 |
| Depreciation | 4 | 3 | 6 | 6 | 8 | 11 | 12 | 10 | 10 | 9 | 34 | 31 | 31 |
| Profit before tax | 8 | 5 | 3 | 6 | 6 | 19 | 21 | 28 | 43 | 39 | 59 | 123 | 152 |
| Tax % | 33% | 43% | 54% | 46% | 44% | 29% | 34% | 31% | 31% | 31% | 32% | 30% | |
| Net Profit | 5 | 3 | 1 | 3 | 4 | 14 | 14 | 20 | 29 | 27 | 40 | 87 | 101 |
| EPS in Rs | 1.40 | 0.70 | 0.33 | 0.66 | 0.71 | 2.71 | 2.77 | 3.75 | 4.97 | 4.51 | 6.68 | 14.29 | 16.63 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 7% | 5% | 6% | 8% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -40.00% | -66.67% | 200.00% | 33.33% | 250.00% | 0.00% | 42.86% | 45.00% | -6.90% | 48.15% | 117.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.67% | 266.67% | -166.67% | 216.67% | -250.00% | 42.86% | 2.14% | -51.90% | 55.04% | 69.35% |
Krishana Phoschem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 53% |
| 3 Years: | 62% |
| TTM: | 42% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 44% |
| 3 Years: | 43% |
| TTM: | 124% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 81% |
| 3 Years: | 53% |
| 1 Year: | 120% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 25% |
Last Updated: September 5, 2025, 9:25 am
Balance Sheet
Last Updated: September 10, 2025, 1:59 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 21 | 21 | 25 | 25 | 25 | 25 | 26 | 30 | 31 | 62 | 62 |
| Reserves | 48 | 52 | 59 | 68 | 71 | 85 | 100 | 121 | 191 | 231 | 239 | 322 |
| Borrowings | 29 | 30 | 32 | 46 | 42 | 32 | 12 | 21 | 70 | 276 | 436 | 376 |
| Other Liabilities | 18 | 19 | 5 | 14 | 11 | 29 | 21 | 27 | 39 | 44 | 108 | 276 |
| Total Liabilities | 112 | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 |
| Fixed Assets | 74 | 72 | 72 | 80 | 112 | 106 | 96 | 94 | 85 | 358 | 322 | 295 |
| CWIP | 0 | 9 | 8 | 25 | 0 | 1 | 0 | 7 | 92 | 3 | 43 | 78 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 38 | 42 | 37 | 48 | 37 | 64 | 62 | 94 | 153 | 220 | 479 | 664 |
| Total Assets | 112 | 122 | 117 | 152 | 149 | 170 | 158 | 195 | 330 | 582 | 845 | 1,036 |
Below is a detailed analysis of the balance sheet data for Krishana Phoschem Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 62.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 62.00 Cr..
- For Reserves, as of Mar 2025, the value is 322.00 Cr.. The value appears strong and on an upward trend. It has increased from 239.00 Cr. (Mar 2024) to 322.00 Cr., marking an increase of 83.00 Cr..
- For Borrowings, as of Mar 2025, the value is 376.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 436.00 Cr. (Mar 2024) to 376.00 Cr., marking a decrease of 60.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 108.00 Cr. (Mar 2024) to 276.00 Cr., marking an increase of 168.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,036.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 845.00 Cr. (Mar 2024) to 1,036.00 Cr., marking an increase of 191.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 295.00 Cr.. The value appears to be declining and may need further review. It has decreased from 322.00 Cr. (Mar 2024) to 295.00 Cr., marking a decrease of 27.00 Cr..
- For CWIP, as of Mar 2025, the value is 78.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2024) to 78.00 Cr., marking an increase of 35.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 664.00 Cr.. The value appears strong and on an upward trend. It has increased from 479.00 Cr. (Mar 2024) to 664.00 Cr., marking an increase of 185.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,036.00 Cr.. The value appears strong and on an upward trend. It has increased from 845.00 Cr. (Mar 2024) to 1,036.00 Cr., marking an increase of 191.00 Cr..
However, the Borrowings (376.00 Cr.) are higher than the Reserves (322.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -14.00 | -20.00 | -20.00 | -31.00 | -23.00 | 1.00 | 23.00 | 18.00 | -14.00 | -224.00 | -307.00 | -192.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 8 | 24 | 62 | 66 | 52 | 53 | 41 | 54 | 60 | 84 | 104 | 102 |
| Inventory Days | 223 | 290 | 97 | 224 | 127 | 157 | 135 | 145 | 103 | 194 | 84 | 60 |
| Days Payable | 72 | 115 | 20 | 94 | 43 | 85 | 22 | 41 | 39 | 16 | 35 | 67 |
| Cash Conversion Cycle | 159 | 200 | 139 | 195 | 136 | 126 | 154 | 158 | 124 | 263 | 154 | 95 |
| Working Capital Days | 17 | 36 | 49 | 57 | 22 | 52 | 87 | 95 | 95 | 64 | 44 | 42 |
| ROCE % | 14% | 11% | 7% | 8% | 9% | 16% | 17% | 20% | 20% | 11% | 15% | 22% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 14.00 | 6.54 | 8.80 | 10.50 | 7.83 |
| Diluted EPS (Rs.) | 14.00 | 6.54 | 8.65 | 10.42 | 7.15 |
| Cash EPS (Rs.) | 19.04 | 12.07 | 11.46 | 13.34 | 11.43 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 62.08 | 48.62 | 84.69 | 74.58 | 56.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 62.08 | 48.62 | 84.69 | 74.58 | 56.36 |
| Dividend / Share (Rs.) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 |
| Revenue From Operations / Share (Rs.) | 219.68 | 149.43 | 104.43 | 107.75 | 72.31 |
| PBDIT / Share (Rs.) | 31.36 | 21.02 | 17.61 | 19.20 | 15.68 |
| PBIT / Share (Rs.) | 26.32 | 15.50 | 14.80 | 15.80 | 11.75 |
| PBT / Share (Rs.) | 19.94 | 9.55 | 12.60 | 14.43 | 10.88 |
| Net Profit / Share (Rs.) | 14.00 | 6.54 | 8.65 | 9.94 | 7.50 |
| PBDIT Margin (%) | 14.27 | 14.06 | 16.86 | 17.81 | 21.67 |
| PBIT Margin (%) | 11.98 | 10.37 | 14.17 | 14.66 | 16.25 |
| PBT Margin (%) | 9.07 | 6.39 | 12.06 | 13.39 | 15.04 |
| Net Profit Margin (%) | 6.37 | 4.37 | 8.28 | 9.22 | 10.37 |
| Return on Networth / Equity (%) | 22.54 | 13.45 | 10.21 | 13.32 | 13.31 |
| Return on Capital Employeed (%) | 27.68 | 19.62 | 10.73 | 16.87 | 19.03 |
| Return On Assets (%) | 8.35 | 4.78 | 4.59 | 8.93 | 10.01 |
| Long Term Debt / Equity (X) | 0.34 | 0.52 | 0.55 | 0.22 | 0.04 |
| Total Debt / Equity (X) | 0.97 | 1.45 | 1.06 | 0.31 | 0.10 |
| Asset Turnover Ratio (%) | 1.44 | 1.29 | 0.70 | 1.22 | 1.07 |
| Current Ratio (X) | 1.41 | 1.33 | 1.36 | 2.58 | 2.43 |
| Quick Ratio (X) | 1.08 | 0.92 | 0.65 | 1.52 | 1.24 |
| Inventory Turnover Ratio (X) | 9.33 | 4.61 | 1.86 | 3.14 | 2.57 |
| Dividend Payout Ratio (NP) (%) | 3.57 | 3.82 | 5.54 | 4.64 | 6.35 |
| Dividend Payout Ratio (CP) (%) | 2.62 | 2.07 | 4.18 | 3.46 | 4.17 |
| Earning Retention Ratio (%) | 96.43 | 96.18 | 94.46 | 95.36 | 93.65 |
| Cash Earning Retention Ratio (%) | 97.38 | 97.93 | 95.82 | 96.54 | 95.83 |
| Interest Coverage Ratio (X) | 4.91 | 3.54 | 7.98 | 14.05 | 17.99 |
| Interest Coverage Ratio (Post Tax) (X) | 3.19 | 2.10 | 4.92 | 8.27 | 9.61 |
| Enterprise Value (Cr.) | 1801.75 | 1938.86 | 1779.52 | 892.61 | 259.52 |
| EV / Net Operating Revenue (X) | 1.33 | 2.10 | 5.51 | 2.79 | 1.38 |
| EV / EBITDA (X) | 9.29 | 14.92 | 32.69 | 15.69 | 6.34 |
| MarketCap / Net Operating Revenue (X) | 1.07 | 1.63 | 4.66 | 2.58 | 1.30 |
| Retention Ratios (%) | 96.42 | 96.17 | 94.45 | 95.35 | 93.64 |
| Price / BV (X) | 3.79 | 5.02 | 5.74 | 3.73 | 1.66 |
| Price / Net Operating Revenue (X) | 1.07 | 1.63 | 4.66 | 2.58 | 1.30 |
| EarningsYield | 0.05 | 0.02 | 0.01 | 0.03 | 0.08 |
After reviewing the key financial ratios for Krishana Phoschem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For Diluted EPS (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.04. This value is within the healthy range. It has increased from 12.07 (Mar 24) to 19.04, marking an increase of 6.97.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 62.08. It has increased from 48.62 (Mar 24) to 62.08, marking an increase of 13.46.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 62.08. It has increased from 48.62 (Mar 24) to 62.08, marking an increase of 13.46.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 219.68. It has increased from 149.43 (Mar 24) to 219.68, marking an increase of 70.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 31.36. This value is within the healthy range. It has increased from 21.02 (Mar 24) to 31.36, marking an increase of 10.34.
- For PBIT / Share (Rs.), as of Mar 25, the value is 26.32. This value is within the healthy range. It has increased from 15.50 (Mar 24) to 26.32, marking an increase of 10.82.
- For PBT / Share (Rs.), as of Mar 25, the value is 19.94. This value is within the healthy range. It has increased from 9.55 (Mar 24) to 19.94, marking an increase of 10.39.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 14.00. This value is within the healthy range. It has increased from 6.54 (Mar 24) to 14.00, marking an increase of 7.46.
- For PBDIT Margin (%), as of Mar 25, the value is 14.27. This value is within the healthy range. It has increased from 14.06 (Mar 24) to 14.27, marking an increase of 0.21.
- For PBIT Margin (%), as of Mar 25, the value is 11.98. This value is within the healthy range. It has increased from 10.37 (Mar 24) to 11.98, marking an increase of 1.61.
- For PBT Margin (%), as of Mar 25, the value is 9.07. This value is below the healthy minimum of 10. It has increased from 6.39 (Mar 24) to 9.07, marking an increase of 2.68.
- For Net Profit Margin (%), as of Mar 25, the value is 6.37. This value is within the healthy range. It has increased from 4.37 (Mar 24) to 6.37, marking an increase of 2.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 22.54. This value is within the healthy range. It has increased from 13.45 (Mar 24) to 22.54, marking an increase of 9.09.
- For Return on Capital Employeed (%), as of Mar 25, the value is 27.68. This value is within the healthy range. It has increased from 19.62 (Mar 24) to 27.68, marking an increase of 8.06.
- For Return On Assets (%), as of Mar 25, the value is 8.35. This value is within the healthy range. It has increased from 4.78 (Mar 24) to 8.35, marking an increase of 3.57.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.34. This value is within the healthy range. It has decreased from 0.52 (Mar 24) to 0.34, marking a decrease of 0.18.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.97. This value is within the healthy range. It has decreased from 1.45 (Mar 24) to 0.97, marking a decrease of 0.48.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.44. It has increased from 1.29 (Mar 24) to 1.44, marking an increase of 0.15.
- For Current Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 1.5. It has increased from 1.33 (Mar 24) to 1.41, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.08. This value is within the healthy range. It has increased from 0.92 (Mar 24) to 1.08, marking an increase of 0.16.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.33. This value exceeds the healthy maximum of 8. It has increased from 4.61 (Mar 24) to 9.33, marking an increase of 4.72.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 20. It has decreased from 3.82 (Mar 24) to 3.57, marking a decrease of 0.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.62. This value is below the healthy minimum of 20. It has increased from 2.07 (Mar 24) to 2.62, marking an increase of 0.55.
- For Earning Retention Ratio (%), as of Mar 25, the value is 96.43. This value exceeds the healthy maximum of 70. It has increased from 96.18 (Mar 24) to 96.43, marking an increase of 0.25.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.38. This value exceeds the healthy maximum of 70. It has decreased from 97.93 (Mar 24) to 97.38, marking a decrease of 0.55.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.91. This value is within the healthy range. It has increased from 3.54 (Mar 24) to 4.91, marking an increase of 1.37.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.19. This value is within the healthy range. It has increased from 2.10 (Mar 24) to 3.19, marking an increase of 1.09.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,801.75. It has decreased from 1,938.86 (Mar 24) to 1,801.75, marking a decrease of 137.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has decreased from 2.10 (Mar 24) to 1.33, marking a decrease of 0.77.
- For EV / EBITDA (X), as of Mar 25, the value is 9.29. This value is within the healthy range. It has decreased from 14.92 (Mar 24) to 9.29, marking a decrease of 5.63.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.07, marking a decrease of 0.56.
- For Retention Ratios (%), as of Mar 25, the value is 96.42. This value exceeds the healthy maximum of 70. It has increased from 96.17 (Mar 24) to 96.42, marking an increase of 0.25.
- For Price / BV (X), as of Mar 25, the value is 3.79. This value exceeds the healthy maximum of 3. It has decreased from 5.02 (Mar 24) to 3.79, marking a decrease of 1.23.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.07, marking a decrease of 0.56.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.05, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Krishana Phoschem Ltd:
- Net Profit Margin: 6.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 27.68% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 22.54% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.19
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.08
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.7 (Industry average Stock P/E: 49.01)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.97
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.37%
Fundamental Analysis of Krishana Phoschem Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Fertilisers | No.5-O-20, Basement, Bhilwara Rajasthan 311001 | secretarial@krishnaphoschem.com http://www.krishnaphoschem.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mahendra Kumar Ostwal | Chairman |
| Mr. Praveen Ostwal | Managing Director |
| Mr. Sunil Kothari | WholeTime Director & CFO |
| Mr. Pankaj Ostwal | Non Executive Director |
| Mr. Pradeep Agarwal | Independent Director |
| Mrs. Priyanka Surana | Independent Director |
| Mr. Bheru Lal Ostwal | Independent Director |
| Mr. Gopal Inani | Independent Director |
Krishana Phoschem Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹222.75 |
| Previous Day | ₹217.40 |
FAQ
What is the intrinsic value of Krishana Phoschem Ltd?
Krishana Phoschem Ltd's intrinsic value (as of 07 December 2025) is 382.19 which is 23.10% lower the current market price of 497.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,011 Cr. market cap, FY2025-2026 high/low of 619/175, reserves of ₹322 Cr, and liabilities of 1,036 Cr.
What is the Market Cap of Krishana Phoschem Ltd?
The Market Cap of Krishana Phoschem Ltd is 3,011 Cr..
What is the current Stock Price of Krishana Phoschem Ltd as on 07 December 2025?
The current stock price of Krishana Phoschem Ltd as on 07 December 2025 is 497.
What is the High / Low of Krishana Phoschem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Krishana Phoschem Ltd stocks is 619/175.
What is the Stock P/E of Krishana Phoschem Ltd?
The Stock P/E of Krishana Phoschem Ltd is 25.7.
What is the Book Value of Krishana Phoschem Ltd?
The Book Value of Krishana Phoschem Ltd is 73.4.
What is the Dividend Yield of Krishana Phoschem Ltd?
The Dividend Yield of Krishana Phoschem Ltd is 0.10 %.
What is the ROCE of Krishana Phoschem Ltd?
The ROCE of Krishana Phoschem Ltd is 21.7 %.
What is the ROE of Krishana Phoschem Ltd?
The ROE of Krishana Phoschem Ltd is 25.3 %.
What is the Face Value of Krishana Phoschem Ltd?
The Face Value of Krishana Phoschem Ltd is 10.0.